Skip to main content
European Statements on Hospital Pharmacy
Menu
Home
About
From the President
Background
What is Hospital Pharmacy ?
Implementation Plan
Implementation Ambassadors
Success timeline
Milestones
Who Supports the Statements?
Support Us
Statements
The European Statements of Hospital Pharmacy
Development
Final Statements
Stakeholders
Information for Stakeholders
Patients
What do Statements mean for the Patient?
Statements Directory
Who Supports the Statements?
Doctors
What do the Statements mean for Doctors?
Statements Directory
Who Supports the Statements?
Nurses
What do the Statements mean for the Nurses and Midwives?
Statements Directory
Who Supports the Statements?
Other Healtcare Professionals
What do the Statements mean for other Healthcare Professionals?
Statements Directory
Who Supports the Statements?
Hospital Managers
What do the Statements mean for Hospital Managers?
Statements Directory
Who Supports the Statements?
Policy Makers
What do the Statements mean for Policy Makers?
Statements Directory
Who Supports the Statements?
Regulators and Insurers
What do the Statements mean for Regulators and Insurers?
Statements Directory
Who supports the statements?
Accrediting Organisations
What does the Statements mean for Accrediting Organisations?
Statements Directory
Who Supports the Statements?
Education Providers
What do the Statements mean for Education Providers?
Statements Directory
Who Supports the Statements?
Technology Providers
What do the Statements mean for the Technology Providers?
Statements Directory
Who Supports the Statements?
Pharmaceutical Industry
What do the Statements mean for the Pharma?
Statements Directory
Who Supports the Statements?
Pharmacy Profession
What do the Statements mean for the Pharmacy profession?
Statements Directory
Who Supports the Statements?
Let us know what you need
Evidence Map
GPI
Statement Implementation Learning Collaborative Centres (SILCC)
Case studies
Why are Case Studies Important ?
Self-assessment
Self-assessment tool
Development
Assess your hospital pharmacy
SILCC
Statement Implementation Learning Collaborative Centres
Apply for the SILCC programme
Map of SILCC Hosts
Surveys
2016 EAHP Statements Survey
Statements Survey 2015
2015 Baseline Survey
Resources
News
News
Statement Implementation Newsletter
Ambassadors Profiles
Media
Photo Galleries
Video Galleries
You are here
Home
Hospital Pharmacy profession
GPI: DEFINING DOSAGE REGIMENS OF ERLOTINIB AND GEFITINIB IN NON-SMALL CELL LUNG CANCER PATIENTS USING MODELLING AND SIMULATION
Document:
GPI: THE ADDITION OF A COST ANALYSIS CHANGES THE OUTCOME OF A TENDER
Document:
PHARMACISTS IMPROVE DOCUMENTATION OF DRUG ALLERGIE
SAFER DRUGS WITH AWARD-WINNING DATABASE
INTEGRATION OF THE CLINICAL PHARMACIST IN A MULTIDISCIPLINARY TEAM IN A BURNS UNIT
Document:
THE PHARMACIST IN THE LUNG CANCER MULTIDISCIPLINARY TEAM
Document:
COMPREHENSIVE SMOKING CESSATION PROGRAMME RUN BY CLINICAL PHARMACIST IN COLLABORATION WITH THE ADDICTOLOGY DEPARTMENT
Document:
USING AN ELECTRONIC ALGORITHM TO IDENTIFY THE MOST RELEVANT PATIENTS FOR MEDICATION REVIEW
Document:
USING AN ELECTRONIC ALGORITHM TO IDENTIFY THE MOST RELEVANT PATIENTS FOR MEDICATION REVIEW
Document:
IMPROVING THE CONTINUITY OF CARE IN CASE OF EXTRATEMPORANEOUS MEDICINES FOR CHILDREN
Document:
Pages
1
2
3
4
5
6
7
8
9
next ›
last »
Follow Us
